The Venous Center

Filter Your Results

 

News

 

Veniti Closes on Equity Financing From Boston Scientific

September 8, 2016 -- Veniti, Inc. has closed on $25 million in a Series D equity financing deal from Boston Scientific Corporation. Veniti is a developer of treatments for dee…

ACP PRO Venous Registry Approved by CMS for Meaningful Use

September 7, 2016 -- The American College of Phlebology (ACP) recently announced that the ACP PRO Venous Registry has been designated a meaningful-use specialized registry by …

Bluegrass Vascular’s Surfacer Inside-Out Access Catheter System Approved in Europe

August 30, 2016 -- Bluegrass Vascular Technologies announced that it has received European CE Mark approval for its Surfacer Inside-Out access catheter system, which is indica…

SVS Announces New Reporting Standards for Thoracic Outlet Syndrome

August 23, 2016 -- The Society for Vascular Surgery (SVS) announced the publication of new reporting standards for thoracic outlet syndrome (TOS) by Karl A. Illig, MD, et al i…

Five Essential Components to Deep Venous Care

Jeffrey Wang, MD

August 2016—As the popularity of performing procedures in the office-based lab (OBL) continues to rise, there is a continued push to expand the capabilities of these labs. Many labs have …

Five Essential Components to Treating Peripheral Artery Disease and Critical Limb Ischemia

Nicholas J. Petruzzi, MD; Lori Richwine, DO; Rajesh Patel, MD; and Michael Schmidling, MD

August 2016—The ability to perform minimally invasive endovascular treatments for peripheral artery disease (PAD) and critical limb ischemia (CLI) in the office-based lab (OBL) is now a w…

FDA Clears Bio2 Medical’s Angel Catheter Including Prophylactic Indication for Pulmonary Embolism

August 24, 2016 -- Bio2 Medical Inc. announced that the Angel catheter has received US Food & Drug Administration (FDA) 510(k) clearance, which includes a prophylactic ind…

Treatment of Complex Femoropopliteal Lesions Using the Turbo-Power Excimer Laser

Ehrin J. Armstrong, MD, MSc

August 2016—Targeting ISR, chronic total occlusions, and heavy thrombus burden with laser atherectomy.

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.